Therapeutic Use of Extracellular Vesicles for Acute and Chronic Lung Disease
Multipotent mesenchymal stem cells (MSCs) possess regenerative properties and have been shown to improve outcomes and survival in acute and chronic lung diseases, but there have been some safety concerns raised related to MSC-based therapy. Subsequent studies have demonstrated that many of the regen...
Main Authors: | Erin N. Worthington, James S. Hagood |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/7/2318 |
Similar Items
-
Clinical Application of Mesenchymal Stem Cell-Derived Extracellular Vesicle-Based Therapeutics for Inflammatory Lung Diseases
by: Yu Fujita, et al.
Published: (2018-10-01) -
Mesenchymal stem cells and extracellular vesicles in therapy against kidney diseases
by: Yuling Huang, et al.
Published: (2021-03-01) -
Emerging role of extracellular vesicles in lung injury and inflammation
by: Zhang Lanyu, et al.
Published: (2019-05-01) -
Extracellular Vesicles from Mesenchymal Stem Cells as Novel Treatments for Musculoskeletal Diseases
by: María José Alcaraz, et al.
Published: (2019-12-01) -
Diagnostic and Therapeutic Applications of Extracellular Vesicles in Interstitial Lung Diseases
by: Abdulrahman Ibrahim, et al.
Published: (2021-01-01)